Immunotherapy in Treating Patients With Resected Liver Metastases From Colon Cancer - Contacts and Locations

Home

Immunotherapy in Treating Patients With Resected Liver Metastases From Colon Cancer

This study has been completed.

Study NCT00003433. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00003433

Locations


United States, North Carolina
	Duke Comprehensive Cancer Center
	Durham, North Carolina, United States, 27710

Sponsors and Collaborators

Duke University

National Cancer Institute (NCI)

Investigators


Study Chair:	Herbert K. Lyerly, MD	Duke University